Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
- Peter Lynch
Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-04-01 | Faulkingham Dell | SVP, CCO | Sell | 952 | $3.40 | $3,237 | No |
| 2021-04-01 | Spellman David A | SVP, CFO and Treasurer | Sell | 790 | $3.40 | $2,686 | No |
| 2021-04-01 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 1,060 | $3.40 | $3,604 | No |
| 2021-04-01 | Dahan Michel | SVP, Chief Operating Officer | Sell | 1,211 | $3.40 | $4,117 | No |
| 2021-04-01 | Butler John P. | CEO and President | Sell | 4,109 | $3.40 | $13,971 | No |
| 2021-04-01 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 1,081 | $3.40 | $3,675 | No |
| 2021-03-01 | Butler John P. | CEO and President | Sell | 49,990 | $3.40 | $169,771 | Yes |
| 2021-03-01 | Faulkingham Dell | CCO | Sell | 6,749 | $3.40 | $22,920 | Yes |
| 2021-03-01 | Dahan Michel | SVP, Chief Operating Officer | Sell | 14,547 | $3.40 | $49,403 | Yes |
| 2021-03-01 | Burke Steven Keith | SVP, Chief Medical Officer | Sell | 7,558 | $3.40 | $25,668 | Yes |
| 2020-06-08 | Smith Cynthia | Director | Sell | 4,567 | $12.10 | $55,261 | Yes |
| 2020-06-08 | GILMAN STEVEN C | Director | Sell | 4,567 | $12.08 | $55,169 | Yes |
| 2020-06-08 | GOWEN MAXINE | Director | Sell | 4,567 | $12.05 | $55,032 | Yes |
| 2020-06-01 | Faulkingham Dell | CCO | Sell | 6,426 | $11.58 | $74,413 | No |
| 2020-02-28 | Dahan Michel | SVP, Chief Operating Officer | Sell | 6,972 | $8.70 | $60,656 | Yes |
| 2020-02-28 | Hadas Nicole R. | SVP, Chief Legal Officer | Sell | 7,050 | $8.70 | $61,335 | Yes |
| 2020-02-28 | Amello Jason | SVP, CFO & Treasurer | Sell | 6,976 | $8.70 | $60,691 | Yes |
| 2020-02-28 | Tubridy Karen L | SVP, Chief Development Officer | Sell | 3,454 | $8.70 | $30,050 | Yes |
| 2019-11-20 | GILMAN STEVEN C | Director | Buy | 5,800 | $3.43 | $19,894 | No |
| 2019-11-20 | Smith Cynthia | Director | Buy | 15,000 | $3.52 | $52,800 | No |
| 2019-11-20 | Burke Steven Keith | SVP, Chief Medical Officer | Buy | 27,000 | $3.58 | $96,660 | No |
| 2019-11-20 | Butler John P. | CEO and President | Buy | 50,000 | $3.44 | $172,000 | No |
| 2019-11-20 | ADAMS ADRIAN | Director | Buy | 50,000 | $3.41 | $170,500 | No |
| 2018-02-15 | Nash Duane | Director | Sell | 1,000 | $14.62 | $14,620 | No |
| 2017-10-02 | Nash Duane | Director | Sell | 1,188 | $19.64 | $23,332 | No |
| 2017-10-02 | Hadas Nicole R. | SVP, General Counsel, Sec. | Sell | 7,803 | $19.89 | $155,188 | No |
| 2017-10-02 | Dahan Michel | SVP, Chief Business Officer | Sell | 1,398 | $19.64 | $27,457 | No |
| 2017-09-28 | Dahan Michel | SVP, Chief Business Officer | Sell | 5,000 | $19.30 | $96,500 | No |
| 2017-08-15 | Dahan Michel | SVP, Chief Business Officer | Sell | 5,000 | $15.00 | $75,000 | No |
| 2017-07-05 | Satter Muneer A | Director | Buy | 1,034,482 | $14.50 | $14,999,989 | No |
Insider Smart
Insider Smart